Evidence map›Paper›PMID 30310364›Full record

ArticleJournal of Korean medical science2018

Tae Hee Lee, Joo-Hee Hwang, Woo Kon Lee, Min-Kyoung Shin, Hye Ryun Woo, Kyung Min Chung, Chang-Seop Lee

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Korean medical science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Molecular survey of aminoglycoside-resistantNew microbes and new infections · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tae Hee LeeDepartment of Microbiology and Immunology, Chonbuk National University Medical School, Jeonju, Korea.ORCID https://orcid.org/0000-0003-3049-8252
Joo-Hee HwangDepartment of Internal Medicine, Chonbuk National University Medical School, Jeonju, Korea.ORCID https://orcid.org/0000-0002-8616-3411
Woo Kon LeeDepartment of Microbiology, College of Medicine, Gyeongsang National University, Jinju, Korea.ORCID https://orcid.org/0000-0003-3913-2265
Min-Kyoung ShinDepartment of Microbiology, College of Medicine, Gyeongsang National University, Jinju, Korea.ORCID https://orcid.org/0000-0003-1782-5351
Hye Ryun WooDepartment of New Biology, Daegu Gyeongbuk Institute of Science & Technology, Daegu, Korea.ORCID https://orcid.org/0000-0002-0546-052X
Kyung Min ChungDepartment of Microbiology and Immunology, Chonbuk National University Medical School, Jeonju, Korea.ORCID https://orcid.org/0000-0001-6414-9187
Chang-Seop LeeDepartment of Internal Medicine, Chonbuk National University Medical School, Jeonju, Korea.ORCID https://orcid.org/0000-0002-2897-2202

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathogenic gram-negatives that produce 16S ribosomal RNA methyltransferases (16S RMTases) have already been distributed all over the world. To investigate the predominance of aminoglycoside resistance associated with 16S RMTases in Korea, we collected a total of 222 amikacin resistant Gram-negative clinical isolates from patient specimens between 1999 and 2015 from three hospital banks across Korea.

Indexed as

AmikacinAnti-Bacterial AgentsBacterial ProteinsDrug Resistance, BacterialGram-Negative BacteriaGram-Negative Bacterial InfectionsHumansMethyltransferasesRepublic of KoreaRNA, Ribosomal, 16SAmikacinAnti-Bacterial AgentsBacterial ProteinsMethyltransferasesRNA, Ribosomal, 16SAminoglycoside ResistanceArmAKoreaRmtB

Identifiers

PMID30310364
PMCPMC6179987

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.